The Role of Intestinal Microbiota and Diet as Modulating Factors in the Course of Alzheimer's and Parkinson's Diseases.

Witold Czarnik, Piotr Fularski, Agata Gajewska, Paulina Jakubowska, Zofia Uszok, Ewelina Młynarska, Jacek Rysz, Beata Franczyk
Author Information
  1. Witold Czarnik: Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland. ORCID
  2. Piotr Fularski: Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland. ORCID
  3. Agata Gajewska: Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland. ORCID
  4. Paulina Jakubowska: Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland. ORCID
  5. Zofia Uszok: Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland. ORCID
  6. Ewelina Młynarska: Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland. ORCID
  7. Jacek Rysz: Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland.
  8. Beata Franczyk: Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland.

Abstract

Many researchers propose manipulating microbiota to prevent and treat related diseases. The brain-gut axis is an object that remains the target of modern research, and it is not without reason that many researchers enrich it with microbiota and diet in its name. Numerous connections and mutual correlations have become the basis for seeking answers to many questions related to pathology as well as human physiology. Disorders of this homeostasis as well as dysbiosis itself accompany neurodegenerative diseases such as Alzheimer's and Parkinson's. Heavily dependent on external factors, modulation of the gut microbiome represents an opportunity to advance the treatment of neurodegenerative diseases. Probiotic interventions, synbiotic interventions, or fecal transplantation can undoubtedly support the biotherapeutic process. A special role is played by diet, which provides metabolites that directly affect the body and the microbiota. A holistic view of the human organism is therefore essential.

Keywords

References

  1. Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3920-5 [PMID: 16473946]
  2. Nutrients. 2022 Jan 17;14(2): [PMID: 35057561]
  3. Dement Geriatr Cogn Dis Extra. 2022 May 30;12(2):100-106 [PMID: 35950150]
  4. BMC Gastroenterol. 2016 Jul 30;16(1):86 [PMID: 27475754]
  5. Sci Rep. 2017 Oct 19;7(1):13537 [PMID: 29051531]
  6. Adv Nutr. 2018 May 1;9(3):193-206 [PMID: 29767701]
  7. Mol Biol Rep. 2023 Feb;50(2):1663-1675 [PMID: 36399245]
  8. ACS Chem Neurosci. 2019 Nov 20;10(11):4704-4715 [PMID: 31661243]
  9. Arch Intern Med. 2008 Apr 14;168(7):713-20 [PMID: 18413553]
  10. World J Gastroenterol. 2015 Aug 7;21(29):8787-803 [PMID: 26269668]
  11. Adv Nutr. 2023 Jul;14(4):819-839 [PMID: 37075947]
  12. Alzheimers Dement. 2019 Jan;15(1):76-92 [PMID: 30337151]
  13. Nutrients. 2022 Nov 24;14(23): [PMID: 36501033]
  14. Handb Clin Neurol. 2019;167:231-255 [PMID: 31753135]
  15. Ann Nutr Metab. 2021;77 Suppl 2:28-35 [PMID: 34500451]
  16. Front Aging Neurosci. 2022 Jun 16;14:903455 [PMID: 35783147]
  17. Nutrients. 2021 Feb 22;13(2): [PMID: 33671575]
  18. Curr Neuropharmacol. 2020;18(11):1106-1125 [PMID: 32484110]
  19. Gastroenterol Rep (Oxf). 2022 May 16;10:goac017 [PMID: 35582476]
  20. Clin Exp Immunol. 2022 Aug 19;209(2):225-235 [PMID: 35647912]
  21. Mol Nutr Food Res. 2024 Jul;68(13):e2300271 [PMID: 37876144]
  22. Mol Neurobiol. 2020 Dec;57(12):5026-5043 [PMID: 32829453]
  23. Nutrients. 2020 May 13;12(5): [PMID: 32414132]
  24. Nutrients. 2023 Jul 19;15(14): [PMID: 37513622]
  25. Cell Host Microbe. 2015 May 13;17(5):690-703 [PMID: 25974306]
  26. Microorganisms. 2023 Mar 28;11(4): [PMID: 37110289]
  27. Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6 [PMID: 18936492]
  28. Front Cell Infect Microbiol. 2023 Jul 10;13:1224155 [PMID: 37492530]
  29. Public Health Nutr. 2011 Dec;14(12A):2274-84 [PMID: 22166184]
  30. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10671-6 [PMID: 12149470]
  31. Nutrients. 2023 May 11;15(10): [PMID: 37242153]
  32. Microorganisms. 2019 Jan 10;7(1): [PMID: 30634578]
  33. Neuron. 2019 Aug 21;103(4):627-641.e7 [PMID: 31255487]
  34. Alzheimers Dement. 2015 Sep;11(9):1007-14 [PMID: 25681666]
  35. Front Cell Infect Microbiol. 2020 Mar 24;10:98 [PMID: 32266160]
  36. Biol Rev Camb Philos Soc. 2022 Apr;97(2):582-599 [PMID: 34734461]
  37. Nucleic Acids Res. 2022 Jan 7;50(D1):D795-D800 [PMID: 34500458]
  38. Int J Mol Sci. 2022 Oct 25;23(21): [PMID: 36361643]
  39. High Throughput. 2020 Jul 29;9(3): [PMID: 32751130]
  40. Front Cell Infect Microbiol. 2021 Mar 17;11:625913 [PMID: 33816335]
  41. J Neurol Neurosurg Psychiatry. 2020 Aug;91(8):795-808 [PMID: 32576618]
  42. J Neurosci. 2002 Jul 15;22(14):5900-9 [PMID: 12122052]
  43. J Neurol Sci. 2022 Mar 15;434:120166 [PMID: 35144237]
  44. Biochim Biophys Acta Proteins Proteom. 2019 Oct;1867(10):890-908 [PMID: 30853581]
  45. Food Chem. 2022 May 1;375:131644 [PMID: 34823942]
  46. Ageing Res Rev. 2021 Sep;70:101397 [PMID: 34214643]
  47. Int J Mol Sci. 2019 Aug 09;20(16): [PMID: 31405021]
  48. J Neurosci. 2003 Oct 29;23(30):9796-804 [PMID: 14586007]
  49. Intern Emerg Med. 2024 Mar;19(2):275-293 [PMID: 37505311]
  50. PLoS One. 2021 Jun 4;16(6):e0252353 [PMID: 34086720]
  51. Adv Nutr. 2019 Nov 1;10(6):1040-1065 [PMID: 31209456]
  52. Front Neurosci. 2023 Feb 02;17:1123967 [PMID: 36816113]
  53. Neurobiol Dis. 2020 Jul;140:104814 [PMID: 32087283]
  54. Front Neurosci. 2023 Apr 27;17:1130730 [PMID: 37179559]
  55. Behav Brain Res. 2023 Jun 25;448:114459 [PMID: 37121278]
  56. Neurobiol Dis. 2022 Aug;170:105780 [PMID: 35654277]
  57. Sci Rep. 2022 Jan 31;12(1):1648 [PMID: 35102266]
  58. Dig Liver Dis. 2014 Jun;46(6):527-34 [PMID: 24629820]
  59. Eur J Neurol. 2023 Apr;30(4):934-942 [PMID: 36692092]
  60. Nat Neurosci. 2015 Jul;18(7):965-77 [PMID: 26030851]
  61. Alzheimers Res Ther. 2018 Dec 22;10(1):124 [PMID: 30579367]
  62. mBio. 2015 Mar 17;6(2):e02481 [PMID: 25784704]
  63. Med Res Rev. 2020 Jul;40(4):1496-1507 [PMID: 31808182]
  64. PLoS Pathog. 2017 Dec 21;13(12):e1006654 [PMID: 29267402]
  65. Exp Mol Med. 2018 Aug 16;50(8):1-9 [PMID: 30115904]
  66. Int J Nanomedicine. 2019 Jul 19;14:5541-5554 [PMID: 31410002]
  67. Nutr Rev. 2022 Jan 10;80(2):271-281 [PMID: 33942080]
  68. Alzheimers Dement. 2022 Mar;18(3):457-468 [PMID: 34310044]
  69. Biology (Basel). 2023 Jan 28;12(2): [PMID: 36829474]
  70. Front Med (Lausanne). 2017 Oct 03;4:163 [PMID: 29043249]
  71. Nutrients. 2019 Aug 14;11(8): [PMID: 31416163]
  72. Front Microbiol. 2016 Sep 26;7:1544 [PMID: 27725817]
  73. Nutrition. 2015 Nov-Dec;31(11-12):1317-23 [PMID: 26283574]
  74. Cell. 2016 Nov 17;167(5):1339-1353.e21 [PMID: 27863247]
  75. Med Clin North Am. 2019 Mar;103(2):263-293 [PMID: 30704681]
  76. Can J Neurol Sci. 2012 Mar;39(2):185-8 [PMID: 22343151]
  77. Sci Rep. 2018 Feb 1;8(1):2183 [PMID: 29391457]
  78. Oxid Med Cell Longev. 2017;2017:6405278 [PMID: 29081890]
  79. Nutrients. 2021 Aug 15;13(8): [PMID: 34444955]
  80. Sci Rep. 2019 Jun 20;9(1):8837 [PMID: 31222050]
  81. Int J Mol Sci. 2022 Dec 21;24(1): [PMID: 36613544]
  82. J Biol Chem. 1999 Nov 12;274(46):32970-4 [PMID: 10551864]
  83. Neurosci Bull. 2018 Dec;34(6):1111-1118 [PMID: 29956105]
  84. Int J Mol Sci. 2022 Dec 20;24(1): [PMID: 36613486]
  85. Front Aging Neurosci. 2022 Oct 14;14:1015837 [PMID: 36313018]
  86. Nature. 2004 Oct 21;431(7011):931-45 [PMID: 15496913]
  87. J Parkinsons Dis. 2019;9(3):501-515 [PMID: 31282427]
  88. J Gen Microbiol. 1947 Sep;1(3):279-98 [PMID: 20270627]
  89. Nat Commun. 2022 Nov 15;13(1):6638 [PMID: 36380002]
  90. Int J Mol Sci. 2022 Oct 14;23(20): [PMID: 36293176]
  91. Ann N Y Acad Sci. 2012 Jul;1259:54-64 [PMID: 22758637]
  92. Front Aging Neurosci. 2023 May 19;15:1171955 [PMID: 37273657]
  93. Eur J Neurol. 2020 Jan;27(1):27-42 [PMID: 31631455]
  94. Biomed Pharmacother. 2023 Jul;163:114816 [PMID: 37150033]
  95. Mov Disord. 2020 Jul;35(7):1208-1217 [PMID: 32357258]
  96. J Clin Biochem Nutr. 2020 Sep;67(2):188-198 [PMID: 33041517]
  97. Int Rev Neurobiol. 2019;147:45-74 [PMID: 31607362]
  98. Gut Microbes. 2020;11(2):135-157 [PMID: 31368397]
  99. J Biol Chem. 2012 Oct 12;287(42):35092-35103 [PMID: 22891247]
  100. BMC Med. 2023 Mar 14;21(1):81 [PMID: 36915130]
  101. Alzheimers Dement. 2015 Sep;11(9):1015-22 [PMID: 26086182]
  102. Mov Disord. 2021 Apr;36(4):977-984 [PMID: 33404118]
  103. Exp Mol Med. 2022 Apr;54(4):433-446 [PMID: 35396575]
  104. Probiotics Antimicrob Proteins. 2020 Sep;12(3):973-979 [PMID: 31677091]
  105. Adv Nutr. 2021 Jul 30;12(4):1239-1285 [PMID: 33693453]

MeSH Term

Humans
Gastrointestinal Microbiome
Parkinson Disease
Alzheimer Disease
Diet
Microbiota
Dysbiosis
Brain

Word Cloud

Created with Highcharts 10.0.0microbiotadiseasesneurodegenerativeresearchersrelatedaxismanydietwellhumanAlzheimer'sParkinson'sinterventionsManyproposemanipulatingpreventtreatbrain-gutobjectremainstargetmodernresearchwithoutreasonenrichnameNumerousconnectionsmutualcorrelationsbecomebasisseekinganswersquestionspathologyphysiologyDisordershomeostasisdysbiosisaccompanyHeavilydependentexternalfactorsmodulationgutmicrobiomerepresentsopportunityadvancetreatmentProbioticsynbioticfecaltransplantationcanundoubtedlysupportbiotherapeuticprocessspecialroleplayedprovidesmetabolitesdirectlyaffectbodyholisticvieworganismthereforeessentialRoleIntestinalMicrobiotaDietModulatingFactorsCourseDiseasesgut-brain

Similar Articles

Cited By